Tego Science acquires approval of ‘ROSMIR,’ Korea’s first cell treatment for wrinkle enhancement
Tego Science(CEO Sae-Hwa Jeon) announced on the 28th that ROSMIR®(project name: TPX-105), an autologous wrinkle reducer, from the Ministry of Food and Drug Safety. With this, Tego Science now owns the highest number of cell therapies only in Korea, but the world.
Meaning ‘dew of miracle’ in Span...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.